First Time Loading...

Theseus Pharmaceuticals Inc
NASDAQ:THRX

Watchlist Manager
Theseus Pharmaceuticals Inc Logo
Theseus Pharmaceuticals Inc
NASDAQ:THRX
Watchlist
Price: 4.06 USD Market Closed
Updated: Apr 28, 2024
Section:
 

Wall Street
Price Targets

THRX Price Targets Summary
Theseus Pharmaceuticals Inc

Wall Street analysts forecast THRX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for THRX is 5.25 USD .

THRX Lowest Forecast
Wall Street Target
Not Available
THRX Average Forecast
Wall Street Target
5.25 USD
29% Upside
THRX Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
5.25 USD
29% Upside
Highest
Price Target
Not Available

THRX Last Price Targets
Theseus Pharmaceuticals Inc

The latest public price target was made on Jun 30, 2022 by Andrew Fein from H.C. Wainwright , who expects THRX stock to rise by 442% over the next 12 months. You can read more about this price target by viewing the article on Pulse 2.0.

Analyst Price Target Date Article
Andrew Fein
H.C. Wainwright
22 USD
Upside 442%
1 year ago
Jun 30, 2022
Theseus Pharmaceuticals (THRX) Stock: Why It Increased Over 6% Today
Pulse 2.0
Andrew Fein
H.C. Wainwright
Price Target 22 USD
Upside/Downside 442%
View Source
Theseus Pharmaceuticals Inc Competitors:
Price Targets
002773
Chengdu Kanghong Pharmaceutical Group Co Ltd
16% Upside
L
503
Lansen Pharmaceutical Holdings Ltd
78% Downside
G
605507
Guobang Pharma Ltd
51% Upside
002349
Jinghua Pharmaceutical Group Co Ltd
299% Upside
002773
Chengdu Kanghong Pharmaceutical Group Co Ltd
16% Upside
L
503
Lansen Pharmaceutical Holdings Ltd
78% Downside
G
605507
Guobang Pharma Ltd
51% Upside
002349
Jinghua Pharmaceutical Group Co Ltd
299% Upside
H
243070
Huons Co Ltd
73% Upside
GLAND
Gland Pharma Ltd
7% Upside
A
AHEALTH
Apex Healthcare Bhd
21% Downside
T
300119
Tianjin Ringpu Bio-Technology Co Ltd
41% Upside

Revenue
Forecast

Revenue Estimate
Theseus Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Theseus Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Theseus Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
THRX intrinsic value, competitors valuation, and company profile.
DCF Valuation
THRX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
THRX stock valuation using valuation multiples.
Wall Street Estimates
THRX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
THRX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is THRX's stock price target?
Price Target
5.25 USD

According to Wall Street analysts, the average 1-year price target for THRX is 5.25 USD .

ALPHA SPREAD
Join more than 132,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.